Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
doi:10.1007/s40266-012-0018-z
View Article European Journal of Pharmacology (1999) "Pharmacological characterisation of Ipamorelin, a new growth hormone secretagogue." View Article Growth Hormone & IGF Research (1999) "Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats." View Article
Research data indicates that the alteration in FOXO proteins may contribute to the disease etiology[6]
The protective effect in vitro was abolished by the GLP-1 receptor antagonist exendin 939, cAMP inhibitors, as well as phosphatidylinositol 3-kinase and mitogen-activated protein kinase inhibitors, suggesting involvement of these pathways in the protective response
Environ Sci Techno 42:23492354
Ipamorelin stays restricted by the FDA because of safety issues along with potential abuse
US$ 21.49
US$ 21.56
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 25.09
US$ 25.44
US$ 28.55
US$ 24.87
